CASI Pharmaceuticals
CASI
#9501
Rank
S$55.58 M
Marketcap
$3.60
Share price
-5.02%
Change (1 day)
-57.54%
Change (1 year)

CASI Pharmaceuticals (CASI) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$67.52 Million

According to CASI Pharmaceuticals's latest financial reports the company's total liabilities are S$67.52 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CASI Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$39.28 M-4.23%
2021-12-31S$41.01 M28.32%
2020-12-31S$31.96 M164.43%
2019-12-31S$12.08 M124.17%
2018-12-31S$5.39 M-38.55%
2017-12-31S$8.77 M-12.5%
2016-12-31S$10.02 M-40.49%
2015-12-31S$16.85 M8.71%
2014-12-31S$15.5 M2064.88%
2013-12-31S$0.71 M-21.17%
2012-12-31S$0.9 M-0.39%
2011-12-31S$0.91 M-73.82%
2010-12-31S$3.48 M-79.31%
2009-12-31S$16.83 M-48.81%
2008-12-31S$32.89 M-12.48%
2007-12-31S$37.58 M179.91%
2006-12-31S$13.42 M14.46%
2005-12-31S$11.73 M95.28%
2004-12-31S$6 M-33.01%
2003-12-31S$8.96 M-70.13%
2002-12-31S$30.01 M-29.52%
2001-12-31S$42.58 M